Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$146.14 USD
-0.68 (-0.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $145.99 -0.15 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
JNJ 146.14 -0.68(-0.46%)
Will JNJ be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for JNJ based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for JNJ
AbbVie (ABBV) Beats on Q1 Earnings & Sales, Ups '24 EPS View
Are You Looking for a High-Growth Dividend Stock?
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
5 Stocks in Focus on Their Recent Dividend Hike
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
Other News for JNJ
7 Stocks to Buy if Inflation Continues to Reign in 2024
Generational Wealth Builders: 3 Stocks to Own for Decades of Gains
What Investing Account Types Are The Best Fit For You And Your Dividends?
5 Stocks In Focus On Their Recent Dividend Hikes
How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?